Home › Funds › B Group, Inc. › FHTX
B Group, Inc. position in FHTX
FOGHORN THERAPEUTICS INC · Health Care
B Group, Inc. reported holding 200,000 shares of FHTX (FOGHORN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$976K, representing 0.46% of its reported portfolio and ranking #19 among its reported holdings. B Group, Inc. has disclosed FHTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How B Group, Inc.'s FHTX position evolved
B Group, Inc. first disclosed a stake in FHTX in Q1 2026 at 102,000 shares (US$488K). The position peaked in Q2 2026 at 200,000 shares, worth US$976K. Across 2 filings, B Group, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 200,000 shares valued at US$976K — an increase of 98,000 shares quarter over quarter.. Notable position changes include a 96% increase in Q2 2026 (shares fell 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 102.00K | $487.56K | New |
| Q2 2026 | 200.00K | $976.00K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FHTX and 13F data
FHTX (FOGHORN THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in FHTX — the largest reported positions include Flagship Pioneering, LLC (US$61.8M), BVF INC/IL (US$28.5M), Euclidean Capital LLC (US$7.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FHTX
- Flagship Pioneering, LLC 12.67M sh · $61.85M · Q2 2026
- BVF INC/IL 5.84M sh · $28.51M · Q2 2026
- Euclidean Capital LLC 1.57M sh · $7.68M · Q2 2026
- Birchview Capital, LP 281.94K sh · $1.38M · Q2 2026
More on B Group, Inc.
FAQ
How long has B Group, Inc. held FHTX?
B Group, Inc. has disclosed FHTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is B Group, Inc.'s current position in FHTX?
As of Q2 2026, B Group, Inc. holds 200.00K shares of FHTX (FOGHORN THERAPEUTICS INC), valued at $976.00K, representing 0.46% of its reported portfolio and ranking #19.
Has B Group, Inc. been buying or selling FHTX?
In the latest 13F filing (Q2 2026), B Group, Inc. increased its position in FHTX. The position peaked in Q2 2026 at 200.00K shares.
Which other funds hold FHTX?
Other major institutional holders of FHTX include Flagship Pioneering, LLC, BVF INC/IL, Euclidean Capital LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.